NasdaqCM - Nasdaq Real Time Price USD
Cyclacel Pharmaceuticals, Inc. (CYCC)
0.2512
+0.0067
+(2.74%)
At close: May 2 at 4:00:01 PM EDT
0.2528
+0.00
+(0.64%)
After hours: May 2 at 7:51:57 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
43
43
420
--
--
Operating Expense
12,047
12,047
25,873
27,656
22,389
Operating Income
-12,004
-12,004
-25,453
-27,656
-22,389
Net Non Operating Interest Income Expense
12
12
266
210
16
Other Income Expense
-2
-2
-364
1,531
188
Pretax Income
-11,994
-11,994
-25,551
-25,915
-22,185
Tax Provision
-782
-782
-2,996
-4,717
-3,728
Net Income Common Stockholders
-11,212
-11,212
-22,756
-21,399
-18,658
Diluted NI Available to Com Stockholders
-11,212
-11,212
-22,756
-21,399
-18,658
Basic EPS
-2.09
--
-26.75
-28.50
-32.10
Diluted EPS
-2.09
--
-26.75
-28.50
-32.10
Basic Average Shares
5,355.3790
--
850.8150
750.3780
595.0780
Diluted Average Shares
5,355.3790
--
850.8150
750.3780
595.0780
Total Operating Income as Reported
-12,004
-12,004
-25,453
-27,656
-22,389
Total Expenses
12,047
12,047
25,873
27,656
22,389
Net Income from Continuing & Discontinued Operation
-11,212
-11,212
-22,555
-21,198
-18,457
Normalized Income
-11,161.5208
-11,161.5208
-22,189.5439
-21,388.5898
-18,493.6062
Interest Income
12
12
266
210
16
Net Interest Income
12
12
266
210
16
EBIT
-12,004
-12,004
-25,453
-27,656
-22,389
EBITDA
-11,998
-11,998
-25,422
-27,624
-22,346
Reconciled Depreciation
6
6
31
32
43
Net Income from Continuing Operation Net Minority Interest
-11,212
-11,212
-22,555
-21,198
-18,457
Total Unusual Items Excluding Goodwill
-54
-54
-414
233
44
Total Unusual Items
-54
-54
-414
233
44
Normalized EBITDA
-11,944
-11,944
-25,008
-27,857
-22,390
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
-3.5208
-3.5208
-48.5439
42.4102
7.3938
12/31/2021 - 3/16/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADIL Adial Pharmaceuticals, Inc.
0.6700
-14.10%
PCSA Processa Pharmaceuticals, Inc.
0.2316
-7.40%
TVGN Tevogen Bio Holdings Inc.
1.0100
+3.23%
IBO Impact BioMedical Inc.
0.7480
+87.00%
SPRB Spruce Biosciences, Inc.
0.0786
0.00%
ONCO Onconetix, Inc.
0.0698
-10.63%
RNAZ TransCode Therapeutics, Inc.
0.5122
-9.18%
GLMD Galmed Pharmaceuticals Ltd.
1.2500
-2.34%
HEPA Hepion Pharmaceuticals, Inc.
0.2846
-2.57%
TNFA TNF Pharmaceuticals, Inc.
0.2012
+0.05%